XML 33 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Total
Issued capital
Capital Surplus
Other capital reserves
Accumulated deficit
Foreign currency translation reserve
Non-controlling interests
Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2021     1,749,127,404          
Equity at beginning of period at Dec. 31, 2021 $ 1,505 $ 586 $ 2 $ 12,753 $ (1,990) $ (1,246) [1] $ (8,933) $ 919
Profit / (loss) for the period (9) (162)       (162) [1]   153
Transfer from OCI to income statement on disposal of subsidiary 558 558         558  
Other comprehensive loss (453) (410)     27   (437) (43)
Total comprehensive income 96 (14)     27 (162) [1] 121 110
Dividends declared (14)             (14)
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity (824)             (824)
Changes in ownership interest in a subsidiary 8 1       (3) 4 7
Other (in shares)     4,229,272          
Other (4) (4)     (4)      
Number of shares outstanding at end of period (in shares) at Dec. 31, 2022     1,753,356,676          
Equity at end of period at Dec. 31, 2022 767 569 $ 2 12,753 (1,967) (1,411) [1] (8,808) 198
Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2022     1,753,356,676          
Equity at beginning of period at Dec. 31, 2022 767 569 $ 2 12,753 (1,967) (1,411) [1] (8,808) 198
Profit / (loss) for the period (2,450) (2,528)       (2,528) [1]   78
Transfer from OCI to income statement on disposal of subsidiary 3,414 3,414         3,414  
Other comprehensive loss (617) (615)     (16) (3) (596) (2)
Total comprehensive income 347 271     (16) (2,531) [1] 2,818 76
Dividends declared (45)             (45)
Disposal of subsidiaries with non-controlling interests (16)             (16)
Other (in shares)     2,608,109          
Other 18 18     15 3 [1]    
Number of shares outstanding at end of period (in shares) at Dec. 31, 2023     1,755,964,785          
Equity at end of period at Dec. 31, 2023 1,071 858 $ 2 12,753 (1,968) (3,939) [1] (5,990) 213
Profit / (loss) for the period 487 415       415 [1]   72
Transfer from OCI to income statement on disposal of subsidiary (36) (36)         (36)  
Other comprehensive loss (172) (158)     (9) (2) [1] (147) (14)
Total comprehensive income 279 221     (9) 413 [1] (183) 58
Dividends declared (83)             (83)
Disposal of subsidiaries with non-controlling interests (22)             (22)
Other (in shares)     9,519,274          
Other 12 20     24 (4) [1]   (8)
Number of shares outstanding at end of period (in shares) at Dec. 31, 2024     1,765,484,059          
Equity at end of period at Dec. 31, 2024 $ 1,257 $ 1,099 $ 2 $ 12,753 $ (1,953) $ (3,530) [1] $ (6,173) $ 158
[1]
* Certain of the consolidated entities of VEON Ltd. are restricted from remitting funds in the form of cash dividends or loans by a variety of regulations, contractual or local statutory requirements, refer to Note 27 for further details.